Advanced or Metastatic Breast Cancer

15 clinical trials · Condition

Record	Firm	Date
Pelareorep and Paclitaxel Injection in Chinese Patients With Advanced or Metastatic Breast Cancer (NCT05519059)	Adlai Nortye Biopharma Co., Ltd.	2021-10-11
A Study of MRG002 in the Treatment of Patients With HER2-low Locally Advanced or Metastatic Breast Cancer (BC) (NCT04742153)	Shanghai Miracogen Inc.	2021-05-13
Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer (NCT04494425)	AstraZeneca	2020-07-24
MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer (NCT03767335)	Menarini Group	2018-11-13
Phase 1b Trial of Dinaciclib With Pembrolizumab for Advanced Breast Cancer (NCT01676753)	Jo Chien	2016-12-28
Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer. (NCT02154776)	Novartis Pharmaceuticals	2014-06-27
Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients (NCT01625286)	AstraZeneca	2012-10-03
Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules (NCT01226316)	AstraZeneca	2010-12-01
A Phase I/II Clinical Trial of Vidaza With Abraxane in Patients With Advanced/Metastatic Solid Tumors and Breast Cancer (NCT00748553)	University of Utah	2008-09-01

Every clearance here is in the API, with alerts when new ones post.